Home Compare TMO
Peer Analysis

Thermo Fisher Scientific Inc. — Peer Companies & Stock Comparisons

Thermo Fisher Scientific Inc.'s functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.

Compare TMO with peers
Comparison TMO peer score
Thermo Fisher Scientific Inc. vs Abbott Laboratories
53 Compare →
Thermo Fisher Scientific Inc. vs Medtronic plc
51 Compare →
Thermo Fisher Scientific Inc. vs Agilent Technologies, Inc.
56 Compare →
Thermo Fisher Scientific Inc. vs IQVIA Holdings Inc.
57 Compare →
Thermo Fisher Scientific Inc. vs GE HealthCare Technologies Inc.
54 Compare →
Thermo Fisher Scientific Inc. vs Fresenius Medical Care AG
63 Compare →
Thermo Fisher Scientific Inc. vs Kenvue Inc.
51 Compare →
Thermo Fisher Scientific Inc. vs Align Technology, Inc.
59 Compare →
Thermo Fisher Scientific Inc. vs Reckitt Benckiser Group plc
81 Compare →

Full TMO analysis in AssetNext

View the complete Thermo Fisher Scientific Inc. report including all peer dimensions.

Open in AssetNext →

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.